Search for: "Pfizer Pharmaceutic, Inc." Results 521 - 540 of 667
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2009, 9:15 am
Pharmaceutical giant, Pfizer Inc, will disclose its compensation paid to U.S. healthcare professionals for consulting, speaking engagements and clinical trials. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs)   General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
5 May 2009, 5:57 am
The cases, both on alleged failure to warn of the risk of suicide, include one against Glaxo over Paxil and one against New York-based Pfizer Inc. over Zoloft. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
27 Mar 2009, 5:15 am
(In the Arkansas Prempro MDL, which consists of thousands of cases, the judge has ordered the plaintiffs to complete discovery involving defendants Pfizer Inc. and Wyeth Pharmaceuticals Inc. by Sept. 1 , 2009) . [read post]
20 Mar 2009, 2:05 am
Pfizer Hospital Products Group, Inc., 783 F.Supp. 1466, 1475 (D. [read post]
9 Mar 2009, 7:24 pm
Wyeth Company may be extremely sensitive to this decision as rival pharmaceutical company Pfizer Inc. is expected to buy out Wyeth for $68 billion later this year. [read post]
19 Feb 2009, 12:55 am
., Nos. 07-4500 and 07-4564 (January 30, 2009).The securities class action against Pharmacia Corporation ("Pharmacia"), Pfizer, Inc. [read post]
17 Feb 2009, 6:53 am
  The case involves a group of investors (collectively, the “Plaintiffs”) alleging that Pharmacia, Inc. and its acquirer, Pfizer, Inc., (collectively, the “Defendants”) violated §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 by making, with scienter, materially false statements about a clinical study of Celebrex. [read post]
10 Feb 2009, 10:34 pm
Pfizer Inc. and Warner-Lambert Co., LLC, No. 1819, Control Nos. 061293/061291, Slip op. [read post]
6 Feb 2009, 8:19 am
(in support of petitioner) Brief amicus curiae of Ivax Pharmaceuticals, Inc. [read post]
3 Feb 2009, 1:40 am
JPMorgan Chase & Co., Bank of America Corp., Barclays Plc, Citigroup Inc. and Goldman Sachs Group Inc. assembled the loan package for Pfizer. [read post]